Cite
HARVARD Citation
Woods, A. et al. (2022). Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor. Pediatric blood & cancer. 69 (2), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Woods, A. et al. (2022). Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor. Pediatric blood & cancer. 69 (2), p. n/a. [Online].